In order to explore how insights from the implementation of non-pharmaceutical interventions (NPIs) during the COVID-19 pandemic may guide further preparedness for COVID-19 – as well as pandemic preparedness and response work in the EU more generally, ECDC organised an expert consultation in June 2022 on the implementation and evaluation of NPIs. This report summarises the findings from that consultation.
This document aims to provide guidance for public health and laboratory experts in identifying human infections with animal influenza viruses as early as possible to provide early warning and inform risk assessments and public health measures.
This Reporting Protocol contains guidelines on how to prepare data for submission to TESSy, deadlines for data submission, subject-specific information, and links to further information.
This pilot protocol is primarily intended to guide the implementation of a first pilot ECDC-funded study using routinely collected data, and includes a concise overview of the systems of the countries included in the pilot study.
This protocol outlines the methods for a prospective cohort study in long-term care facilities (LTCFs) to evaluate the effectiveness of COVID-19 vaccines in preventing laboratory-confirmed SARS-CoV-2 symptomatic infection in LTCF residents.
This key provides the non-specialist with reference material to help recognise an invasive mosquito species and gives details on the morphology to help with verification.
This document outlines operational considerations to support the continuity of national surveillance systems and public health laboratories for epidemiological and virological surveillance for influenza, SARS-CoV-2, and potentially other respiratory viruses in the 2022/2023 winter season and beyond.